Illumina Inc.
9885 Towne Centre Drive
San Diego,
CA 92121
Phone: 858-202-4500
Fax: 858-587-4297
Web Site: http://www.illumina.com
| Illumina, Inc. engages in the development, manufacture, and marketing of life science tools and integrated systems for the analysis of genetic variation and biological function. Its single-nucleotide polymorphism (SNP) genotyping product comprises Array Matrix, which uses a universal format that allows it to analyze various sets of SNPs. The company also offers BeadLabs and BeadStations for gene expression profiling; BeadArray Reader, a scanning instrument that uses a laser to read the results of experiments that are captured in its instruments; and oligos, which are components of the reagent kits for its BeadArray products and are used for assay development. Illumina distributes its products through distributors to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as to academic or private research centers in North America, Europe, Japan, Singapore, and the Pacific Rim countries. The company also develops and commercializes genetic analysis technologies used to perform a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis. It has a strategic collaboration with Invitrogen Corporation for the manufacture, marketing, and distribution of oligos; and deCODE genetics, ehf. to develop and commercialize diagnostic tests for variants in genes involved in disease related pathways linked to heart attack, type 2 diabetes, and breast cancer. The company was founded in 1998 and is based in San Diego, California. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Mr. Jay T. Flatley , 55
Chief Exec. Officer, Pres
|
N/A
|
N/A |
Dr. John R. Stuelpnagel D.V.M., 50
Co-Founder, Chief Operating Officer, Sr. VP, Gen. Mang. of Microarray Bus.
|
N/A
|
N/A |
Dr. David R. Walt Ph.D., 55
Founder, Chairman Scientific Advisory Board, Director and Member of Nominating & Corp. Governance Committee
|
$
25.00K |
N/A |
Mr. Christian O. Henry , 39
Chief Financial Officer, Principal Accounting Officer and Sr. VP
|
N/A
|
N/A |
Mr. Tristan B. Orpin , 42
Sr. VP of Commercial Operations
|
$
244.00K |
$
902.00K |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
Profile
